Neuronally differentiated macula densa cells regulate tissue remodeling and regeneration in the kidney
Authors:
- Georgina GyarmatiGGGeorgina Gyarmati
- Urvi Nikhil ShroffUSUrvi Nikhil Shroff
- Anne Riquier-BrisonARAnne Riquier-Brison
- Dorinne DespositoDDDorinne Desposito
- Wenjun JuWJWenjun Ju
- Sean D. StockerSSSean D. Stocker
- Audrey IzuharaAIAudrey Izuhara
- Sachin DeepakSDSachin Deepak
- James L. BurfordJBJames L. Burford
- Hiroyuki KadoyaHKHiroyuki Kadoya
- Ju-Young MoonJMJu-Young Moon
Open Access
- 10 April 2024
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (11)
Abstract
Tissue regeneration is limited in several organs, including the kidney, contributing to the high prevalence of kidney disease globally. However, evolutionary and physiological adaptive responses and the presence of renal progenitor cells suggest an existing remodeling capacity. This study uncovered endogenous tissue remodeling mechanisms in the kidney that were activated by the loss of body fluid and salt and regulated by a unique niche of a minority renal cell type called the macula densa (MD). Here, we identified neuronal differentiation features of MD cells that sense the local and systemic environment and secrete angiogenic, growth, and extracellular matrix remodeling factors, cytokines and chemokines, and control resident progenitor cells. Serial intravital imaging, MD nerve growth factor receptor and Wnt mouse models, and transcriptome analysis revealed cellular and molecular mechanisms of these MD functions. Human and therapeutic translation studies illustrated the clinical potential of MD factors, including CCN1, as a urinary biomarker and therapeutic target in chronic kidney disease. The concept that a neuronally differentiated key sensory and regulatory cell type responding to organ-specific physiological inputs controls local progenitors to remodel or repair tissues may be applicable to other organs and diverse tissue-regenerative therapeutic strategies.Keywords
All Related Versions
Funding Information
- National Institutes of Health (DK064324)
- National Institutes of Health (DK123564)
- National Institutes of Health (DK135290,S10OD021833,2P30-DK-081943)
- National Institutes of Health (DK135290)
This publication has 67 references indexed in Scilit:
- Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension1Kidney International, 2002
- Low Chloride Stimulation of Prostaglandin E2Release and Cyclooxygenase-2 Expression in a Mouse Macula Densa Cell LineJournal of Biological Chemistry, 2000
- Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical eventsKidney International, 2000
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997
- Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. Activation of intra- and interdomain electron transfer.Journal of Biological Chemistry, 1994
- Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.Journal of Clinical Investigation, 1994
- Expression of nitric oxide synthase in kidney macula densa cellsKidney International, 1992
- Chaos in blood flow control in genetic and renovascular hypertensive ratsAmerican Journal of Physiology-Renal Physiology, 1991
- Direct evidence for apical Na+:2Cl-:K+ cotransport in macula densa cellsAmerican Journal of Physiology-Renal Physiology, 1990
- TGF‐mediated oscillations in the proximal intratubular pressure: differences between spontaneously hypertensive rats and Wistar‐Kyoto ratsActa Physiologica Scandinavica, 1986